Circulating tumor cells in urological cancers

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Circulating tumor cells (CTC) represent a very small subpopulation of the cancer cells found in the bloodstream of patients in the metastatic phase of neoplastic disease. Due to the timeline of the disease, they are regarded as a negative prognostic marker. This study focused on determining CTC percentages; these values vary between different types of cancer. In addition to their diagnostic use, CTCs may also be used to treat the disease. Calculating CTC population size and analyzing their biology in patients in advanced stages of cancer may prove valuable in creating a molecular profile for the disease. This would strongly encourage diagnostics and enable personalized treatment. We here present an analysis of recent data on CTCs in urological cancers and their potential uses.

Cite

CITATION STYLE

APA

Cegan, M., Kobierzycki, C., Kolostova, K., Kiss, I., Bobek, V., & Grill, R. (2017, October 20). Circulating tumor cells in urological cancers. Folia Histochemica et Cytobiologica. Via Medica. https://doi.org/10.5603/FHC.a2017.0015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free